DEXAMETHASONE SODIUM PHOSPHATE
DEXAMETHASONE SODIUM PHOSPHATE is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: DEXAMETHASONE SODIUM PHOSPHATE; Generic name: DEXAMETHASONE SODIUM PHOSPHATE; Manufacturer: HF Acquisition Co LLC, DBA HealthFirst.
| Brand name | DEXAMETHASONE SODIUM PHOSPHATE |
|---|---|
| Generic name | DEXAMETHASONE SODIUM PHOSPHATE |
| Manufacturer | HF Acquisition Co LLC, DBA HealthFirst |
| Dosage | A. Intravenous or intramuscular administration. The initial dosage of Dexamethasone Sodium Phosphate Injection may vary from 0.50 mg/day to 9.0 mg/day depending on the specific disease entity being treated. In situations of less severity, lower doses will generally suffice while in selected patients higher initial doses may be required. Usually the parenteral dosage ranges are one-third to one-half the oral dose given every 12 hours. However, in certain overwhelming, acute, life-threatening situ |
| Warnings | Serious Neurologic Adverse Reactions with Epidural Administration Serious neurologic events, some resulting in death, have been reported with epidural injection of corticosteroids. Specific events reported include, but are not limited to, spinal cord infarction, paraplegia, quadriplegia, cortical blindness, and stroke. These serious neurologic events have been reported with and without use of fluoroscopy. The safety and effectiveness of epidural administration of corticosteroids have not been es |
| Active ingredient(s) | DEXAMETHASONE SODIUM PHOSPHATE |
| Route | INTRA-ARTICULAR |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=18a70010-6cc5-19e2-e063-6394a90a0ea6 |